skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines reslizumabQuestion & answer

reslizumab · Medicine question

What is the contraindication to Cinqaero (reslizumab)?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Cinqaero (reslizumab) is contraindicated in patients with hypersensitivity to reslizumab or any of the excipients listed in section 6.1.

Sources for this answer

Cinqaero (reslizumab) 10 mg/mL concentrate for solution for infusionTeva Pharmaceuticals Ltd · emc · SmPC §4.3 Contraindications · Version 8Document updated 17 July 2023

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

More questions about reslizumab

How long should an infusion of Cinqaero (reslizumab) take?How much sodium is in each 2.5 mL and 10 mL vial of Cinqaero (reslizumab)?How should unopened vials of Cinqaero (reslizumab) concentrate for solution for infusion be stored?Should Cinqaero (reslizumab) concentrate for solution for infusion be shaken before use?What details should be recorded when Cinqaero (reslizumab) is administered to ensure traceability?What does Cinqaero (reslizumab) concentrate for solution for infusion look like?

reslizumab

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the reslizumab guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX